• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清三叶因子 3 预测溃疡性结肠炎患者的疾病活动度。

Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.

机构信息

Clinic of Gastroenterology, "Tsaritsa Yoanna - ISUL" University Hospital, Medical University of Sofia, Sofia, Bulgaria.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):788-794. doi: 10.26355/eurrev_201901_16893.

DOI:10.26355/eurrev_201901_16893
PMID:30720187
Abstract

OBJECTIVE

In this study, we aimed to evaluate the role of serum trefoil factor 3 (TFF3) as a biomarker of disease activity in patients with inflammatory bowel disease (IBD) and to compare TFF3 values with those of fecal calprotectin (FC).

PATIENTS AND METHODS

128 patients with IBD were divided into four groups: 1) active ulcerative colitis (UC); 2) quiescent UC; 3) active Crohn's disease (CD); 4) quiescent CD. The serum levels of TFF3 and FC levels were assessed in all patients and 16 controls.

RESULTS

Patients with active UC had higher TFF3 levels than those with quiescent UC (p<0.001), those with active (p<0.001) or quiescent CD (p<0.001) and controls (p <0.001). We found a correlation between TFF3 and FC values in patients with active (r = 0.478, p = 0.006) and quiescent UC (r=0.528, p=0.002). TFF3 levels correlated with endoscopic activity in UC (evaluated by UC Endoscopic Index of Severity - UCEIS) (r=0.662, p<0.001).

CONCLUSIONS

Serum TFF3 is able to identify patients with active UC. It could be used as a marker to predict disease activity in patients with UC.

摘要

目的

本研究旨在评估血清三叶因子 3(TFF3)作为炎症性肠病(IBD)患者疾病活动的生物标志物的作用,并将 TFF3 值与粪便钙卫蛋白(FC)进行比较。

患者和方法

128 例 IBD 患者分为四组:1)活动期溃疡性结肠炎(UC);2)缓解期 UC;3)活动期克罗恩病(CD);4)缓解期 CD。所有患者和 16 名对照均评估了 TFF3 和 FC 水平。

结果

活动期 UC 患者的 TFF3 水平高于缓解期 UC 患者(p<0.001)、活动期(p<0.001)或缓解期 CD 患者(p<0.001)和对照组(p<0.001)。我们发现活动期和缓解期 UC 患者的 TFF3 值与 FC 值之间存在相关性(r=0.478,p=0.006;r=0.528,p=0.002)。TFF3 水平与 UC 的内镜活动相关(用 UC 内镜严重程度指数评估 - UCEIS)(r=0.662,p<0.001)。

结论

血清 TFF3 能够识别活动期 UC 患者。它可以用作预测 UC 患者疾病活动的标志物。

相似文献

1
Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.血清三叶因子 3 预测溃疡性结肠炎患者的疾病活动度。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):788-794. doi: 10.26355/eurrev_201901_16893.
2
Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.三叶因子 3 独立于 C-反应蛋白,对溃疡性结肠炎患者的完全黏膜愈合具有高度预测性。
J Gastrointestin Liver Dis. 2019 Jun 1;28:169-174. doi: 10.15403/jgld-177.
3
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.非侵入性评估在监测炎症性肠病活动中的疗效:中国的一项前瞻性研究。
World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.
4
Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer.血清三叶因子 3 作为埃及溃疡性结肠炎患者疾病活动的预测因子及其在结直肠癌中的作用。
Egypt J Immunol. 2024 Oct;31(4):27-35.
5
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.粪便钙卫蛋白可预测溃疡性结肠炎患者的黏膜完全愈合,且与溃疡性结肠炎内镜严重程度指数的相关性优于与梅奥内镜亚评分的相关性。
BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7.
6
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
7
Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.采用三叶因子肽评估儿童炎症性肠病活动度。
Pediatr Res. 2020 Nov;88(5):792-795. doi: 10.1038/s41390-020-0812-y. Epub 2020 Mar 2.
8
MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.微小RNA-320a监测炎症性肠病患者的肠道疾病活动度
Clin Transl Gastroenterol. 2020 Mar;11(3):e00134. doi: 10.14309/ctg.0000000000000134.
9
Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.溃疡性结肠炎临床缓解患者粪便标志物与放大内镜分层的相关性。
Digestion. 2018;97(1):82-89. doi: 10.1159/000484223. Epub 2018 Feb 1.
10
Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.联合使用常见粪便和血液标志物检测内镜下活动性炎症性肠病
Clin Transl Gastroenterol. 2020 Mar;11(3):e00138. doi: 10.14309/ctg.0000000000000138.

引用本文的文献

1
Wall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut.韧性之壁:肠道上皮如何预防肠道炎症侵袭
Cell Mol Gastroenterol Hepatol. 2025;19(2):101423. doi: 10.1016/j.jcmgh.2024.101423. Epub 2024 Oct 24.
2
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?海洋藻类及其衍生生物分子用于炎症性肠病的管理:减少肠道炎症和氧化应激标志物的潜在临床治疗方法?
Mar Drugs. 2024 Jul 25;22(8):336. doi: 10.3390/md22080336.
3
Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond.
炎症性肠病的诊断程序:实验室检查、内镜检查、病理学检查、影像学检查及其他
Diagnostics (Basel). 2024 Jun 28;14(13):1384. doi: 10.3390/diagnostics14131384.
4
Salivary trefoil factor family peptide 3 (TFF3) and flow rate in persons with and without obstructive sleep apnea: A preliminary study.唾液三叶因子家族肽 3(TFF3)和流速在阻塞性睡眠呼吸暂停患者和无阻塞性睡眠呼吸暂停患者中的初步研究。
Clin Exp Dent Res. 2023 Oct;9(5):935-941. doi: 10.1002/cre2.746. Epub 2023 May 14.
5
Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology.推进组学方法和新技术时代炎症性肠病的精准管理。
World J Gastroenterol. 2023 Jan 14;29(2):272-285. doi: 10.3748/wjg.v29.i2.272.
6
Intestinal Injury Biomarkers Predict Mortality in Pediatric Severe Malaria.肠损伤生物标志物预测儿童严重疟疾的死亡率。
mBio. 2022 Oct 26;13(5):e0132522. doi: 10.1128/mbio.01325-22. Epub 2022 Sep 7.
7
Gut biomolecules (I-FABP, TFF3 and lipocalin-2) are associated with linear growth and biomarkers of environmental enteric dysfunction (EED) in Bangladeshi children.肠道生物分子(I-FABP、TFF3 和脂联素-2)与孟加拉国儿童的线性生长和环境肠道功能障碍(EED)的生物标志物有关。
Sci Rep. 2022 Aug 16;12(1):13905. doi: 10.1038/s41598-022-18141-8.
8
Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.粪便钙卫蛋白在评估成人炎症性肠病黏膜愈合中的应用:一项荟萃分析
J Clin Med. 2021 May 19;10(10):2203. doi: 10.3390/jcm10102203.
9
Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).胃肠化生严重程度预测胃癌风险:一项前瞻性多中心队列研究(GCEP)。
Gut. 2022 May;71(5):854-863. doi: 10.1136/gutjnl-2021-324057. Epub 2021 May 11.
10
Pretreatment with intestinal trefoil factor alleviates stress-induced gastric mucosal damage Akt signaling.肠道三叶因子预处理可减轻应激诱导的胃黏膜损伤及Akt信号传导。
World J Gastroenterol. 2020 Dec 28;26(48):7619-7632. doi: 10.3748/wjg.v26.i48.7619.